All In Biotech

Free tool

FAERS Monitor: Aggrastat

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020912 or its brand name (Aggrastat, Tirofiban Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,780

Serious

2,466

89% of reports

Hospitalization

401

Death reported

442

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • haemorrhage376
  • thrombocytopenia295
  • myocardial infarction206
  • angina pectoris187
  • haemorrhage intracranial179
  • death146
  • cardiac failure acute118
  • cerebral haemorrhage110
  • acute respiratory failure99
  • cardiac failure88
  • vascular stent thrombosis80
  • infarction53
  • drug ineffective48
  • cardiogenic shock45
  • acute myocardial infarction44

Reports by year received

View as table
YearReports
200445
2005169
2006134
200759
200819
20097
201010
201111
201231
201315
201412
201514
201644
201774
201898
20191,159
2020236
2021137
2022305
202323
202466
202529
202683

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,379 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
vascular stent thrombosisSignal80309.6248.323,345
cardiac failure acuteSignal118136.4114.215,454
haemorrhage intracranialSignal17991.779.515,782
infarctionSignal5359.045.22,945
angina pectorisSignal18749.743.28,827
acute respiratory failureSignal9939.132.23,625
haemorrhageSignal37627.324.99,517
cardiogenic shockSignal4523.817.8958
cerebral haemorrhageSignal11023.319.42,324
thrombocytopeniaSignal29520.018.05,323
acute myocardial infarctionSignal4411.38.4403
myocardial infarctionSignal2068.97.81,456
cardiac failureSignal888.36.8559
death1461.31.19
drug ineffective480.30.297

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.